Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3102 (LINC03102)
- Target
- LINC03102
- Molecular classification
- Long non-coding RNA, Other
01
Overview
Long intergenic non-protein coding RNA 3102 (LINC03102) is a human long non-coding RNA (lncRNA) encoded at the locus ENSG00000226088 and also known as HHLA3-AS1 or HHLA3 antisense RNA 1[1][4][7][8]. LINC03102 is classified as a long intergenic non-coding RNA, meaning it does not encode a protein and is transcribed from a region of the genome distinct from protein-coding genes[1][3][4][8]. Like other lincRNAs, it may participate in chromatin modification and gene expression regulation, processes that are increasingly recognized in normal biology and disease, including cancer[5]. However, there is no direct experimental evidence that LINC03102 itself is a therapeutic target, nor are there known drugs or clinical biomarkers specific to this RNA. Its biological roles and disease associations remain largely uncharacterized.
- Other names
- HHLA3-AS1HHLA3 antisense RNA 1
02
Biological functions
Chromatin modification (by analogy with other lincRNAs)Gene expression regulationOther
03
Disease associations
Possible regulatory roles in Cancer (by analogy with lincRNAs; no direct evidence specific to LINC03102)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 3102 (LINC03102).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3102 (LINC03102).